Healthcare Professionals
Important Safety Information
Healthcare Professionals
Sign Up for Support
Elderly woman sitting in a chair holding a baby
Elderly woman sitting in a chair holding a baby

How treatment works

Actor portrayals.

RYBREVANT FASPRO™ and RYBREVANT® are not chemotherapy—they are targeted treatments that
work with LAZCLUZE®
(lazertinib) to fight cancer

RYBREVANT FASPRO™ and RYBREVANT® each work against EGFR+ cancer in 2 ways:

Helps stop the activity cancer cells use to grow and spread

LAZCLUZE® also stops the activity cancer cells use to grow and spread.

AND

Activates your immune system to help destroy cancer cells

RYBREVANT FASPRO™ and RYBREVANT® are both made of amivantamab, a targeted treatment that works against EGFR and MET receptors.
RYBREVANT FASPRO™ also includes hyaluronidase, which helps your body absorb the medication as an injection under your skin.
RYBREVANT FASPRO™ is not recommended for people who have had allergic reactions to hyaluronidase or any of its ingredients.

*Exon 19 deletion or exon 21 L858R substitution mutations.

EGFR+, mutated epidermal growth factor receptor; MET, mesenchymal-epithelial transition; NSCLC, non–small cell lung cancer.

Man rubbing his arm
Man rubbing his arm

About side effects

Learn more about the side effects that you may experience during treatment with RYBREVANT FASPRO™ + LAZCLUZE® or RYBREVANT® + LAZCLUZE®.

Elderly woman smiling happily outdoors
Elderly woman smiling happily outdoors

Savings & support

Once prescribed RYBREVANT FASPRO™ or RYBREVANT®, connect with a Care Navigator for your support needs.

The support and resources provided by RYBREVANT withMe are not intended to provide medical advice, replace a treatment plan you receive from your doctor or nurse, or serve as a reason for you to start or stay on treatment.